What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?
Matthias PreusserMarjolein GeurtsJohannes A HainfellnerMartin J van den BentPublished in: Neuro-oncology (2023)
Keyphrases